XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - 8 months ended Dec. 31, 2023 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance–May 1, 2023 (Inception) at Apr. 30, 2023
Beginning balance, shares at Apr. 30, 2023      
Founder shares issued to initial stockholders $ 172 24,828 25,000
Founder shares issued to initial stockholders(1), shares 1,725,000      
Proceeds from sale of IPO Units $ 690 68,999,310 69,000,000
Proceeds from sale of IPO Units, shares 6,900,000      
Proceeds from sale of Private Placement Units $ 25 2,530,425 2,530,450
Proceeds from sale of Private Placement Units, shares 253,045      
Issuance of representative shares $ 7 (7)
Issuance of representative shares, shares 69,000      
Common stock subject to possible redemption $ (690) (69,689,310) (69,690,000)
Common stock subject to possible redemption, shares (6,900,000)      
Underwriter commissions (2,415,000) (2,415,000)
Offering costs (1,097,729) (1,097,729)
Accretion of additional paid in capital to accumulated deficit 1,647,476 (1,647,476)
Remeasurement of common stock subject to possible redemption (631,524) (631,524)
Net income 535,209 535,209
Balance–December 31, 2023 at Dec. 31, 2023 $ 204 $ (1,743,798) $ (1,743,594)
Ending balance, shares at Dec. 31, 2023 2,047,045